http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101670100-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bd83b39d95eb4c9a2052faf80545496 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate | 2009-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_585ba7529c399ec31ff4cce9dc4ebb00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_534714553e60393e7b01fc3ea8f69de7 |
| publicationDate | 2010-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-101670100-A |
| titleOfInvention | Tolerogenic tumor-cell antigen-loaded dendritic cell, preparation method and application thereof |
| abstract | The invention provides a tolerogenic tumor-cell antigen-loaded dendritic cell, a preparation method of the dendritic cell, application of the dendritic cell to preparing an anti-cancer drug, and vaccine comprising the tolerogenic tumor-cell antigen-loaded dendritic cell. The invention further comprises the preparation method of a tolerogenic tumor cell and application thereof. The drug prepared bythe tolerogenic tumor-cell antigen-loaded dendritic cell and an immunological composition comprising the dendritic cell can kill the tumor cells which cause cancer recurrence in vivo and in vitro, which provides probability for overcoming cancer tolerance and treating cancer recurrence and cancer metastasis. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102559598-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102925412-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102154208-A |
| priorityDate | 2009-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 282.